Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 105, Issue 7

Comparative pathogenesis of three Mayaro virus genotypes in the cynomolgus macaque No Access

Abstract

Mayaro virus (MAYV), a mosquito-borne alphavirus, is considered an emerging threat to public health with epidemic potential. Phylogenetic studies show the existence of three MAYV genotypes. In this study, we provide a preliminary analysis of the pathogenesis of all three MAYV genotypes in cynomolgus macaques (, Mauritian origin). Significant MAYV-specific RNAemia and viremia were detected during acute infection in animals challenged intravenously with the three MAYV genotypes, and strong neutralizing antibody responses were observed. MAYV RNA was detected at high levels in lymphoid tissues, joint muscle and synovia over 1 month after infection, suggesting that this model could serve as a promising tool in studying MAYV-induced chronic arthralgia, which can persist for years. Significant leucopenia was observed across all MAYV genotypes, peaking with RNAemia. Notable differences in the severity of acute RNAemia and composition of cytokine responses were observed among the three MAYV genotypes. Our model showed no outward signs of clinical disease, but several major endpoints for future MAYV pathology and intervention studies are described. Disruptions to normal blood cell counts and cytokine responses were markedly distinct from those observed in macaque models of CHIKV infection, underlining the importance of developing non-human primate models specific to MAYV infection.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): alphavirus , cynomolgus macaque , Mayaro virus , MAYV pathogenesis and non-human primate model
© 2024 BIOQUAL, Inc.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.002001
2024-07-12
2025-06-18
Loading full text...

Full text loading...

References

  1. Acosta-Ampudia Y, Monsalve DM, Rodríguez Y, Pacheco Y, Anaya J-M et al. Mayaro: an emerging viral threat?. Emerg Microbes Infect 2018; 7:163 [View Article] [PubMed]
     [Google Scholar]
  2. Lorenz C, Freitas Ribeiro A, Chiaravalloti-Neto F. Mayaro virus distribution in South America. Acta Trop 2019; 198:105093 2019 Jul 17 [View Article] [PubMed]
     [Google Scholar]
  3. Diagne CT, Bengue M, Choumet V, Hamel R, Pompon J et al. Mayaro virus pathogenesis and transmission mechanisms. Pathogens 2020; 9:738 [View Article] [PubMed]
     [Google Scholar]
  4. Caicedo EY, Charniga K, Rueda A, Dorigatti I, Mendez Y et al. The epidemiology of Mayaro virus in the Americas: a systematic review and key parameter estimates for outbreak modelling. PLoS Negl Trop Dis 2021; 15:e0009418 [View Article] [PubMed]
     [Google Scholar]
  5. Anderson CR, Downs WG, Wattley GH, Ahin NW, Reese AA. Mayaro virus: a new human disease agent. II. Isolation from blood of patients in Trinidad, B.W.I. Am J Trop Med Hyg 1957; 6:1012–1016 [View Article] [PubMed]
     [Google Scholar]
  6. Causey OR, Maroja OM. Mayaro virus: a new human disease agent. III. Investigation of an epidemic of acute febrile illness on the river Guama in Pará, Brazil, and isolation of Mayaro virus as causative agent. Am J Trop Med Hyg 1957; 6:1017–1023 [PubMed]
     [Google Scholar]
  7. Schaeffer M, Gajdusek DC, Lema AB, Eichenwald H. Epidemic jungle fevers among Okinawan colonists in the Bolivian rain forest. I. Epidemiology. Am J Trop Med Hyg 1959; 8:372–396 [View Article] [PubMed]
     [Google Scholar]
  8. Pinheiro FP, Freitas RB, Travassos da Rosa JF, Gabbay YB, Mello WA et al. An outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical and virological findings. Am J Trop Med Hyg 1981; 30:674–681 [View Article] [PubMed]
     [Google Scholar]
  9. Azevedo RS, Silva EV, Carvalho VL, Rodrigues SG, Nunes-Neto JP et al. Mayaro fever virus, Brazilian Amazon. Emerg Infect Dis 2009; 15:1830–1832 [View Article] [PubMed]
     [Google Scholar]
  10. Auguste AJ, Liria J, Forrester NL, Giambalvo D, Moncada M et al. Evolutionary and ecological characterization of Mayaro virus strains isolated during an outbreak, Venezuela, 2010. Emerg Infect Dis 2015; 21:1742–1750 [View Article] [PubMed]
     [Google Scholar]
  11. Blohm G, Elbadry MA, Mavian C, Stephenson C, Loeb J et al. Mayaro as a Caribbean traveler: evidence for multiple introductions and transmission of the virus into Haiti. Int J Infect Dis 2019; 87:151–153 [View Article] [PubMed]
     [Google Scholar]
  12. Mavian C, Rife BD, Dollar JJ, Cella E, Ciccozzi M et al. Emergence of recombinant Mayaro virus strains from the Amazon basin. Sci Rep 2017; 7:8718 [View Article] [PubMed]
     [Google Scholar]
  13. Mota MT, Vedovello D, Estofolete C, Malossi CD, Araújo JP et al. Complete genome sequence of Mayaro virus imported from the Amazon basin to São Paulo State, Brazil. Genome Announc 2015; 3:e01341-15 [View Article] [PubMed]
     [Google Scholar]
  14. Hoch AL, Peterson NE, LeDuc JW, Pinheiro FP, Travassos da Rosa AP. An outbreak of Mayaro virus disease in Belterra, Brazil. II. Epidemiology and ecological studies. Am J Trop Med Hyg 1981; 30:689–698 [View Article] [PubMed]
     [Google Scholar]
  15. Galindo P, Srihongse S, De Rodaniche E, Grayson MA. An ecological survey for arboviruses in Almirante, Panama, 1959-1962. Am J Trop Med Hyg 1966; 15:385–400 [View Article] [PubMed]
     [Google Scholar]
  16. Serra OP, Cardoso BF, Ribeiro ALM, Santos F dos, Slhessarenko RD. Mayaro virus and dengue virus 1 and 4 natural infection in culicids from Cuiabá, state of Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 2016; 111:20–29 [View Article] [PubMed]
     [Google Scholar]
  17. Groot H, Morales A, Vidales H. Virus isolations from forest mosquitoes in San Vicente de Chucuri, Colombia. Am J Trop Med Hyg 1961; 10:397–402 [View Article] [PubMed]
     [Google Scholar]
  18. Maia LMS, Bezerra MCF, Costa MCS, Souza EM, Oliveira MEB et al. Natural vertical infection by dengue virus serotype 4, Zika virus and Mayaro virus in Aedes (Stegomyia) aegypti and Aedes (Stegomyia) albopictus. Med Vet Entomol 2019; 33:437–442 [View Article] [PubMed]
     [Google Scholar]
  19. Long KC, Ziegler SA, Thangamani S, Hausser NL, Kochel TJ et al. Experimental transmission of Mayaro virus by Aedes aegypti. Am J Trop Med Hyg 2011; 85:750–757 [View Article] [PubMed]
     [Google Scholar]
  20. Smith GC, Francy DB. Laboratory studies of a Brazilian strain of Aedes albopictus as a potential vector of Mayaro and Oropouche viruses. J Am Mosq Control Assoc 1991; 7:89–93 [PubMed]
     [Google Scholar]
  21. Hotez PJ, Murray KO. Dengue, West Nile virus, chikungunya, Zika-and now Mayaro?. PLoS Negl Trop Dis 2017; 11:e0005462 [View Article] [PubMed]
     [Google Scholar]
  22. Diop F, Alout H, Diagne CT, Bengue M, Baronti C et al. Differential susceptibility and innate immune response of Aedes aegypti and Aedes albopictus to the Haitian strain of the Mayaro virus. Viruses 2019; 11:924 [View Article] [PubMed]
     [Google Scholar]
  23. Wiggins K, Eastmond B, Alto BW. Transmission potential of Mayaro virus in Florida Aedes aegypti and Aedes albopictus mosquitoes. Med Vet Entomol 2018; 32:436–442 [View Article] [PubMed]
     [Google Scholar]
  24. Brustolin M, Pujhari S, Henderson CA, Rasgon JL. Anopheles mosquitoes may drive invasion and transmission of Mayaro virus across geographically diverse regions. PLoS Negl Trop Dis 2018; 12:e0006895 [View Article] [PubMed]
     [Google Scholar]
  25. Tsetsarkin KA, Chen R, Weaver SC. Interspecies transmission and chikungunya virus emergence. Curr Opin Virol 2016; 16:143–150 [View Article] [PubMed]
     [Google Scholar]
  26. Díaz-González EE, Kautz TF, Dorantes-Delgado A, Malo-García IR, Laguna-Aguilar M et al. First report of Aedes aegypti transmission of chikungunya virus in the Americas. Am J Trop Med Hyg 2015; 93:1325–1329 [View Article] [PubMed]
     [Google Scholar]
  27. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3:e201 [View Article] [PubMed]
     [Google Scholar]
  28. Semenza JC, Suk JE. Vector-borne diseases and climate change: a European perspective. FEMS Microbiol Lett 2018; 365:fnx244 [View Article] [PubMed]
     [Google Scholar]
  29. Gould EA, Higgs S. Impact of climate change and other factors on emerging arbovirus diseases. Trans R Soc Trop Med Hyg 2009; 103:109–121 [View Article] [PubMed]
     [Google Scholar]
  30. Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res 2010; 85:328–345 [View Article] [PubMed]
     [Google Scholar]
  31. Halsey ES, Siles C, Guevara C, Vilcarromero S, Jhonston EJ et al. Mayaro virus infection, Amazon Basin region, Peru, 2010-2013. Emerg Infect Dis 2013; 19:1839–1842 [View Article] [PubMed]
     [Google Scholar]
  32. Santiago FW, Halsey ES, Siles C, Vilcarromero S, Guevara C et al. Long-term Arthralgia after Mayaro virus infection correlates with sustained pro-inflammatory cytokine response. PLoS Negl Trop Dis 2015; 9:e0004104 [View Article] [PubMed]
     [Google Scholar]
  33. Mota MTO, Costa VV, Sugimoto MA, Guimarães G de F, Queiroz-Junior CM et al. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease. Sci Rep 2020; 10:5306 [View Article] [PubMed]
     [Google Scholar]
  34. Figueiredo CM, Neris RLDS, Gavino-Leopoldino D, da Silva MOL, Almeida JS et al. Mayaro virus replication restriction and induction of muscular inflammation in mice are dependent on age, type-I interferon response, and adaptive immunity. Front Microbiol 2019; 10:2246 [View Article] [PubMed]
     [Google Scholar]
  35. Weise WJ, Hermance ME, Forrester N, Adams AP, Langsjoen R et al. A novel live-attenuated vaccine candidate for mayaro fever. PLoS Negl Trop Dis 2014; 8:e2969 [View Article] [PubMed]
     [Google Scholar]
  36. Powers JM, Haese NN, Denton M, Ando T, Kreklywich C et al. Non-replicating adenovirus based Mayaro virus vaccine elicits protective immune responses and cross protects against other alphaviruses. PLoS Negl Trop Dis 2021; 15:e0009308 [View Article] [PubMed]
     [Google Scholar]
  37. Earnest JT, Basore K, Roy V, Bailey AL, Wang D et al. Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity. J Exp Med 2019; 216:2282–2301 [View Article] [PubMed]
     [Google Scholar]
  38. Campos RK, Preciado-Llanes L, Azar SR, Kim YC, Brandon O et al. Adenoviral-vectored Mayaro and chikungunya virus vaccine candidates afford partial cross-protection from lethal challenge in A129 mouse model. Front Immunol 2020; 11:591885 [View Article] [PubMed]
     [Google Scholar]
  39. Ferraz AC, Almeida LT, da Silva Caetano CC, da Silva Menegatto MB, Souza Lima RL et al. Hepatoprotective, antioxidant, anti-inflammatory, and antiviral activities of silymarin against mayaro virus infection. Antiviral Res 2021; 194:105168 [View Article] [PubMed]
     [Google Scholar]
  40. Choi H, Kudchodkar SB, Reuschel EL, Asija K, Borole P et al. Protective immunity by an engineered DNA vaccine for Mayaro virus. PLoS Negl Trop Dis 2019; 13:e0007042 [View Article] [PubMed]
     [Google Scholar]
  41. Bengue M, Pintong AR, Liegeois F, Nougairède A, Hamel R et al. Favipiravir inhibits Mayaro virus infection in mice. Viruses 2021; 13:2213 [View Article] [PubMed]
     [Google Scholar]
  42. Baldon LVR, de Mendonça SF, Ferreira FV, Rezende FO, Amadou SCG et al. AG129 Mice as a comprehensive model for the experimental assessment of mosquito vector competence for arboviruses. Pathogens 2022; 11:879 [View Article] [PubMed]
     [Google Scholar]
  43. Mota MTO, Costa VV, Sugimoto MA, Guimarães G de F, Queiroz-Junior CM et al. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease. Sci Rep 2020; 10:5306 [View Article] [PubMed]
     [Google Scholar]
  44. Chirathaworn C, Chansaenroj J, Poovorawan Y. Cytokines and chemokines in chikungunya virus infection: protection or induction of pathology. Pathogens 2020; 9:415 [View Article] [PubMed]
     [Google Scholar]
  45. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 120:894–906 [View Article] [PubMed]
     [Google Scholar]
  46. Mota MTO, Costa VV, Sugimoto MA, Guimarães G de F, Queiroz-Junior CM et al. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease. Sci Rep 2020; 10:5306 [View Article] [PubMed]
     [Google Scholar]
  47. Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg 1956; 54:177–191 [View Article] [PubMed]
     [Google Scholar]
  48. Chen CI, Clark DC, Pesavento P, Lerche NW, Luciw PA et al. Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model. Am J Trop Med Hyg 2010; 83:1249–1258 [View Article] [PubMed]
     [Google Scholar]
  49. Herron ICT, Laws TR, Nelson M. Marmosets as models of infectious diseases. Front Cell Infect Microbiol 2024; 14:1340017 [View Article] [PubMed]
     [Google Scholar]
  50. Grimm D. U.S., European researchers face monkey shortage crisis. Science 2023; 380:567–568 [View Article] [PubMed]
     [Google Scholar]
  51. Webb EM, Azar SR, Haller SL, Langsjoen RM, Cuthbert CE et al. Effects of chikungunya virus immunity on Mayaro virus disease and epidemic potential. Sci Rep 2019; 9:20399 [View Article] [PubMed]
     [Google Scholar]
  52. da Silva Caetano CC, Camini FC, Almeida LT, Ferraz AC, da Silva TF et al. Mayaro virus induction of oxidative stress is associated with liver pathology in a non-lethal mouse model. Sci Rep 2019; 9:15289 [View Article] [PubMed]
     [Google Scholar]
  53. Tsetsarkin KA, Chen R, Sherman MB, Weaver SC. Chikungunya virus: evolution and genetic determinants of emergence. Curr Opin Virol 2011; 1:310–317 [View Article] [PubMed]
     [Google Scholar]
  54. Tsetsarkin KA, Chen R, Yun R, Rossi SL, Plante KS et al. Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes. Nat Commun 2014; 5:4084 [View Article] [PubMed]
     [Google Scholar]
  55. Liu Y, Liu J, Du S, Shan C, Nie K et al. Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 2017; 545:482–486 [View Article] [PubMed]
     [Google Scholar]
  56. Weber WC, Labriola CS, Kreklywich CN, Ray K, Haese NN et al. Mayaro virus pathogenesis and immunity in rhesus macaques. PLoS Negl Trop Dis 2023; 17:e0011742 [View Article] [PubMed]
     [Google Scholar]
  57. Broeckel R, Haese N, Messaoudi I, Streblow DN. Nonhuman primate models of chikungunya virus infection and disease (CHIKV NHP Model). Pathogens 2015; 4:662–681 [View Article] [PubMed]
     [Google Scholar]
  58. Silva-Ramos CR, Mejorano-Fonseca JA, Hidalgo M, Rodríguez-Morales AJ, Faccini-Martínez ÁA. Clinical, epidemiological, and laboratory features of Mayaro virus infection: a systematic review. Curr Trop Med Rep 2023; 10:309–319 [View Article]
     [Google Scholar]
  59. Mota MTO, Costa VV, Sugimoto MA, Guimarães G de F, Queiroz-Junior CM et al. In-depth characterization of a novel live-attenuated Mayaro virus vaccine candidate using an immunocompetent mouse model of Mayaro disease. Sci Rep 2020; 10:5306 [View Article] [PubMed]
     [Google Scholar]
  60. Santoshi RK, Patel R, Patel NS, Bansro V, Chhabra G. A comprehensive review of Thrombocytopenia with a spotlight on intensive care patients. Cureus 2022; 14:e27718 [View Article] [PubMed]
     [Google Scholar]
  61. Kafai NM, Diamond MS, Fox JM. Distinct cellular tropism and immune responses to alphavirus infection. Annu Rev Immunol 2022; 40:615–649 [View Article] [PubMed]
     [Google Scholar]
  62. Santos FM, Dias RS, de Oliveira MD, Costa ICTA, Fernandes L de S et al. Animal model of arthritis and myositis induced by the Mayaro virus. PLoS Negl Trop Dis 2019; 13:e0007375 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jgv/10.1099/jgv.0.002001
Loading
Comparative pathogenesis of three Mayaro virus genotypes in the cynomolgus macaque
J. Gen. Virol. 105, 002001 (2024); https://doi.org/10.1099/jgv.0.002001
/content/journal/jgv/10.1099/jgv.0.002001
/content/journal/jgv/10.1099/jgv.0.002001
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error